Study the therapeutic mechanism of Amomum compactum in gentamicin-induced acute kidney injury rat based on a back propagation neural network algorithm

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1040, Issue , 2017, Pages 81-88

  Wang, Xiye ^a   Chen, Hongmei ^a,b   Chang, Chun ^a,b   Jiang, Mingyang ^a,c   Wang, Xiulan ^a,b   Xu, Liang ^a  

^a INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^b Mongolian Medicine Engineering Technology Research Institute of Inner Mongolia   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Acute kidney injury; Amomum compactum; BP neural network algorithm; Gentamicin; Metabonomics; UPLC MS

Indexed keywords

BACKPROPAGATION ALGORITHMS; BIOMARKERS; DISCRIMINANT ANALYSIS; LEAST SQUARES APPROXIMATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; NEGATIVE IONS; NEURAL NETWORKS; PHOSPHOLIPIDS; POSITIVE IONS;

ACUTE KIDNEY INJURY; AMOMUM COMPACTUM; BP NEURAL NETWORKS; GENTAMICIN; METABONOMICS;

BACKPROPAGATION;

AMOMUM COMPACTUM EXTRACT; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; GENTAMICIN; PHYTOSPHINGOSINE; PLANT EXTRACT; SPHINGOMYELIN; SPHINGOSINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; HERBACEOUS AGENT; PHOSPHOLIPID;

ACUTE KIDNEY FAILURE; ALGORITHM; AMOMUM; AMOMUM COMPACTUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACK PROPAGATION; BACK PROPAGATION NEURAL NETWORK ALGORITHM; CHINESE MEDICINE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; GENTAMICIN INDUCED ACUTE KIDNEY INJURY; LOW DRUG DOSE; MALE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RAT; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ACUTE KIDNEY INJURY; ANIMAL; ARTIFICIAL NEURAL NETWORK; CHEMICALLY INDUCED; CHEMISTRY; DISCRIMINANT ANALYSIS; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; METABOLISM; METABOLOMICS; PATHOLOGY; PROCEDURES; WISTAR RAT;

ACUTE KIDNEY INJURY; AMOMUM; ANIMALS; ANTI-BACTERIAL AGENTS; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISCRIMINANT ANALYSIS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENTAMICINS; KIDNEY; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; NEURAL NETWORKS (COMPUTER); PHOSPHOLIPIDS; RATS; RATS, WISTAR;

EID: 85003794191     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.12.002     Document Type: Article

References (38)

1. [1] Jill, V., Nic, V., Wim, V.B., Prevention and conservation management of acute kidney injury. Minerva Urol. Nefrol. 68 (2016), 58–71.
2. [2] Xia, D.M., Lu, H.T., Shi, X., Hao, X.W., Gao, X.Y., Yang, F., Chen, W., Dong, X., Cisplatin nephrotoxicity metabolomics studies based on UHPLC/Q-TOF MS technology. J. Med Res. 45 (2016), 34–39.
3. [3] Shi, Y., Wang, L.F., Luo, P., Sun, B., Li, X.J., Dong, D.L., Ren, L.Q., Expression of kidney injury molecule-1 in rat model of acute kidney injury induced by gentamicin. Chin. J. Biologicals 23 (2010), 700–703.
4. [4] Chen, X., Zhang, Y., Zhu, Z., Liu, H., Guo, H., Xiong, C., Xie, K., Zhang, X., Su, S., Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats. Mol. Med. Rep. 13 (2016), 3953–3960.
5. [5] Gao, S.Y., Chen, W., Peng, Z.J., Li, N., Su, L., Lv, D.Y., Li, L., Lin, Q.S., Dong, X., Guo, Z.Y., Lou, Z.Y., Urinary metabonomics elucidate the therapeutic mechanism of orthosiphon stamineus in mouse crystal-induced kidney injury. J. Ethnopharmacol. 166 (2015), 323–332.
6. [6] Abuelezz, S.A., Hendawy, N., Abdel Gawad, S., Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin-induced nephrotoxicity. J. Pharm. Pharmacol. 68 (2016), 523–532.
7. ε-(carboxyethyl)lysine(CEL). Toxicol. Lett. 219 (2013), 85–92.
8. [8] Pradeep, G., Subroto, C., Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells. J. Biol. Chem. 262 (1987), 12550–12556.
9. [9] Zeng, Z., Fu, L., Ye, X.N., Zhang, T., Meng, S.J., Meng, C.Y., Comparison of volatile oil components from fructus amomi rotundus, fructus galangae semen alpiniae katsumadai and semen myristicae. Chin. J. Appl. Chem. 29 (2012), 1316–1323.
10. [10] Lee, J.A., Lee, M.Y., Seo, C.S., Jung, D.Y., Lee, N.H., Kim, J.H., Ha, H., Shin, H.K., Anti-asthmatic effects of an Amomum compactum extract on an ovalbumin(OVA)-induced murine asthma model. Biosci. Biotechnol. Biochem. 74 (2010), 1814–1818.
11. [11] Feng, X., Jiang, Z.T., Li, R., Deng, J., Study on free radical scavenging potential of cardamom essential oil obtained from China and India. Sci. Technol. Food Ind. 33 (2012), 137–139.
12. [12] Lee, J.A., Lee, M.Y., Shin, I.S., Seo, C.S., Ha, H., Shin, H.K., Anti-inflammatory effects of Amomum compactum on RAW 264.7 cells via induction of heme oxygenase-1. Arch. Pharm. Res. 35 (2012), 739–746.
13. [13] Cao, J., Cui, H., Shi, H., Jiao, L., Big data: a parallel particle swarm optimazation-back-propagation neural network algorithm based on MapReduce. PLoS One, 11, 2016, e0157551, 10.1371/journal. pone.0157551.
14. [14] Hu, H.P., Niu, Z.J., Bai, Y.P., Tan, X.H., Cancer classification based on gene expression using neural networks. Genet. Mol. Res. 14 (2015), 17605–17611.
15. [15] Er, O., Cetin, O., Bascil, M.S., Temurtas, F., A comparative study on Parkinson's disease diagnosis using neural networks and artificial immune system. J. Med. Imaging Health Inf. 6 (2016), 264–268.
16. [16] Wongsathan, R., Pothong, P., Heart disease classification using artificial neural networks. Appl. Mech. Mater. 781 (2015), 624–627.
17. [17] Deng, W.K., Wang, Y.B., Liu, Z.X., Cheng, H., Xue, Y., Heml: a toolkit for illustrating heatmaps. PLoS One, 10, 2015, e0143684, 10.1371/journal.Pone.0143684.
18. [18] Jung, O., Patnaik, S., Marugan, J., Sidransky, E., Westbroek, W., Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease. Expert Rev. Proteomics 21 (2016), 1–9.
19. [19] Luzio, J.P., Pryor, P.R., Bright, N.A., Lysosmes: fusion and function. Nat. Rev. Mol. Cell Biol. 8 (2007), 622–632.
20. [20] Silverblatt, F.J., Kuehn, C., Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 15 (1979), 335–345.
21. [21] Kosek, J.D., Mazze, R.I., Cousins, M.J., Nephrotoxicity of gentamicin. Lab. Invest. 30 (1974), 48–57.
22. [22] Whelton, A., Solez, K., Aminoglycoside nephrotoxicity − a tale of two transports. J. Lab. Clin. Med. 99 (1982), 148–155.
23. [23] Rao, S., Walters, K.B., Wilson, L., Chen, B., Bolisetty, S., Graves, D., Barnes, S., Aqarwal, A., Kabarowski, J.H., Early lipids changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging. Am. J. Physiol. Renal Physiol. 310 (2016), F1136–F1147, 10.1152/ajprenal.00100.2016.
24. [24] Nguyen, T.K., Greg, S., David, K.O., Berhnard, A., Manfred, B., Peter, H.B., Urinary lipid changes during the development of chemically-induced renal papillary necrosis: a study using mefenamic acid and N-phenylanthranilic acid. Biomarkers 6 (2001), 417–427.
25. [25] Wada, A., Tojo, H., Suqiura, T., Fujiwara, Y., Kamada, T., Ueda, N., Okamoto, M., Group II phospholipase A2 as an autocrine growth factor mediating interleukin-1 action on mesangial cells. Biochim. Biophys. Acta 1345 (1997), 99–108.
26. [26] Hara, S., Kobayashi, N., Sakamoto, K., Ueno, T., Manabe, S., Takashima, Y., Hamada, J., Pastan, I., Fukamizu, A., Matsusaka, T., Nagata, M., Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am. J. Pathol. 185 (2015), 2118–2131.
27. [27] Chuang, W.L., Pacheco, J., Cooper, S., Kingsbury, J.S., Hinds, J., Wolf, P., Oliva, P., Keutzer, J., Cox, G.F., Zhang, K., Improved sensitivity of an acid sphingomyelinase activity assay using a C6:0 sphingomyelin substrate. Mol. Genet Metab. Rep. 3 (2015), 55–57.
28. [28] Braun, F., Rinschen, M.M., Bartels, V., Frommolt, P., Habermann, B., Hoeijmarkers, J.H., Schumacher, B., Dolle, M.E., Muller, R.U., Benzing, T., Schermer, B., Kurschat, C.E., Altered lipid metabolism in the aging kidney identified by three layered omic analysis. Aging 8 (2016), 441–457.
29. [29] Tasaki, M., Shimizu, A., Hanekamp, I., Torabi, R., Villani, V., Yamada, K., Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation. J. Am. Soc. Nephrol. 25 (2014), 737–744.
30. [30] Deng, Y.H., Lan, T., Huang, J., Huang, H.Q., Sphingosine Kinase-1/sphingosine 1-phosphate pathway in diabetic nephropathy. Chin. Med. J. 127 (2014), 3004–3010.
31. [31] Zhang, J., Yan, L., Chen, W., Lin, L., Song, X., Yan, X., Hang, W., Huang, B., Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal. Chim. Acta 650 (2009), 16–22.
32. [32] Ritter, J.K., Li, G., Xia, M., Boini, K., Anandamide and its metabolites: what are their roles in the kidney?. Front. Biosci. 8 (2016), 264–277.
33. [33] Rikke, N., Tae-Hwan, K., Ørgen, F.J., Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney. Kidney Res. Clin. Pract. 34 (2015), 194–200.
34. [34] Kwon, T.H., RrØkiær, J., Han, J.S., Knepper, M.A., Nielsen, S., Decreased abundance of major Na(+) transporters in kidney of rats with ischemia-induced acute renal failure. Am. J. Physiol. Renal Physiol. 278 (2000), 925–937.
35. [35] Brater, D.C., Renal effects of cyclooxygenase-2-selective inhibitors. J. Pain Symptom Manage. 23 (2002), 15–20.
36. [36] Mederle, K., Meurer, M., Castrop, H., Höcherl, K., Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice. Am. J. Physiol. Renal Physiol. 309 (2015), 332–340.
37. [37] Sklyarov, A.Y., Panasyuk, N.B., Fomenko, I.S., Pole of nitric oxide-synthase and cyclooxygenase/lipoxygenase systems in development of experimental ulcerative colitis. J. Physiol. Pharmacol. 62 (2011), 65–73.
38. [38] Otunctemur, A., Ozbek, E., Cakir, S.S., Dursun, M., Cekmen, M., Polat, E.C., Ozcan, L., Somay, A., Ozbay, N., Beneficial effects montelukast cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats. Int. Braz. J. Urol. 41 (2015), 279–287.